Abstract
Heart failure, a worldwide health problem, is most commonly due to ischemic cardiomyopathy (ICM) with previous myocardial infarction(s). Herein, insights into the infarct scar as living tissue (and which resembles heart valve leaflets) are reviewed. This includes: a) its population of persistent, metabolically active myofibroblasts, whose elaboration of angiotensin II regulates (via AT1 receptor-ligand binding) their production of TGF-β1 and, in turn, type I fibrillar collagen; b) its neovasculature, which nourishes these fibroblast-like cells; and c) its contractile tonus. Scar tissue myofibroblasts regulate the accumulation of collagen found at sites remote to the infarct and it is this interstitial fibrosis that represents a major component to the adverse structural remodeling seen in ICM. The management of heart failure due to ICM therefore needs to take into account the behavior of infarct scar myofibroblasts.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, Weaver WD. 2002. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) Study. J Am Coll Cardiol 39:60–69.
Kannel WB. 1997. Epidemiology of heart failure in the United States. In: Poole-Wilson PA, Colucci WS, Massie BM, Chatterjee K, Coats AJS, editors. Heart Failure. Scientific Principles and Clinical Practice. New York: Churchill Livingstone; p. 279–288.
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. 1991. The SOLVD Investigators. N Engl J Med 325:293–302.
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. 1992. The SOLVD Investigators. N Engl J Med 327:685–691.
Anversa P, Cheng W, Liu Y, Leri A, Redaelli G, Kajstura J. 1998. Apoptosis and myocardial infarction. Basic Res Cardiol 93(Suppl 3):8–12.
Anversa P, Kajstura J, Olivetti G. 1996. Myocyte death in heart failure. Curr Opin Cardiol 11:245–251.
Levine SA. 1929. Coronary thrombosis: its various clinical features. Medicine 8:245–418.
Mallory GK, White PD, Salcedo-Salgar J. 1939. The speed of healing of myocardial infarction. A study of the pathologic anatomy in seventy-two cases. Am Heart J 18:647–671.
Lodge-Patch I. 1951. The ageing of cardiac infarcts, and its influence on cardiac rupture. Br Heart J 13:37–42.
Cotran RS, Kumar V, Robbins SL. 1989. Robbins’ Pathologic Basis of Disease. 4th ed. Philadelphia: W B Saunders.
Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Quaini F, Sonnenblick EH, Olivetti G, Anversa P. 1994. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 89:151–163.
Cleutjens JPM, Kandala JC, Guarda E, Guntaka RV, Weber KT 1995. Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol 27:1281–1292.
Sun Y, Zhang JQ, Zhang J, Lamparter S. 2000. Cardiac remodeling by fibrous tissue after infarction in rats. J Lab Clin Med 135:316–323.
Li J, Brown LF, Hibberd MG, Grossman JD, Morgan JP, Simons M. 1996. VEGF, fik-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol 270:H1803–H1811.
Sun Y, Weber KT. 1996. Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart. J Mol Cell Cardiol 28:851–858.
Sun Y, Weber KT. 1996. Cells expressing angiotensin II receptors in fibrous tissue of rat heart. Car-diovasc Res 31:518–525.
Cleutjens JPM, Verluyten MJA, Smits JFM, Daemen MJAP. 1995. Collagen remodeling after myocardial infarction in the rat heart. Am J Pathol 147:325–338.
Filip DA, Radu A, Simionescu M. 1986. Interstitial cells of the heart valves possess characteristics similar to smooth muscle cells. Circ Res 59:310–320.
Messier RH, Bass BL, Aly HM, Jones JL, Domkowski PW, Wallace RB, Hopkins RA. 1994. Dual structural and functional phenotypes of the porcine aortic valve interstitial population: characteristics of the leaflet myofibroblast. J Surg Res 57:1–21.
Taylor PM, Allen SP, Yacoub MH. 2000. Phenotypic and functional characterization of interstitial cells from human heart valves, pericardium and skin. J Heart Valve Dis 9:150–158.
Chester AH, Misfeld M, Yacoub MH. 2000. Receptor-mediated contraction of aortic valve leaflets. J Heart Valve Dis 9:250–254.
Katwa LC, Ratajska A, Cleutjens JPM, Sun Y, Zhou G, Lee SJ, Weber KT. 1995. Angiotensin converting enzyme and kininase-II-like activities in cultured valvular interstitial cells of the rat heart. Cardiovasc Res 29:57–64.
Katwa LC, Tyagi SC, Campbell SE, Lee SJ, Cicila GT, Weber KT. 1996. Valvular interstitial cells express angiotensinogen, cathepsin D, and generate angiotensin peptides. Int J Biochem Cell Biol 28:807–821.
Yamada H, Fabris B, Allen AM, Jackson B, Johnston CI, Mendelsohn FAO. 1991. Localization of angiotensin converting enzyme in rat heart. Circ Res 68:141–149.
Pinto JE, Viglione P, Saavedra JM. 1991. Autoradiographic localization and quantification of rat heart angiotensin converting enzyme. Am J Hypertens 4:321–326.
Sun Y, Diaz-Arias AA, Weber KT. 1994. Angiotensin-Converting enzyme, bradykinin and angiotensin II receptor binding in rat skin, tendon and heart valves: an in vitro quantitative autoradiographic study. J Lab Clin Med 123:372–377.
Katwa LC, Campbell SE, Tyagi SC, Lee SJ, Cicila GT, Weber KT. 1997. Cultured myofibroblasts generate angiotensin peptides de novo. J Mol Cell Cardiol 29:1375–1386.
Campbell SE, Katwa LC. 1997. Angiotensin II stimulated expression of transforming growth factor-β1 in cardiac fibroblasts and myofibroblasts. J Mol Cell Cardiol 29:1947–1958.
Sun Y, Zhang J, Zhang JQ, Weber KT. 2001. Renin expression at sites of repair in the infarcted rat heart. J Mol Cell Cardiol 33:995–1003.
Passier RC, Smits JF, Verluyten MJ, Daemen MJ. 1996. Expression and localization of renin and angiotensinogen in rat heart after myocardial infarction. Am J Physiol 271:H1040–H1048.
Ou R, Sun Y, Ganjam VK, Weber KT. 1996. In situ production of angiotensin II by fibrosed rat pericardium. J Mol Cell Cardiol 28:1319–1327.
Yamagishi H, Kim S, Nishikimi T, Takeuchi K, Takeda T. 1993. Contribution of cardiac renin-angiotensin system to ventricular remodelling in myocardial-infarcted rats. J Mol Cell Cardiol 25:1369–1380.
Sun Y, Zhang JQ, Zhang J, Ramires FJA. 1998. Angiotensin II, transforming growth factor-β1 and repair in the infarcted heart. J Mol Cell Cardiol 30:1559–1569.
Katwa LC, Sun Y, Campbell SE, Tyagi SC, Dhalla AK, Kandala JC, Weber KT. 1998. Pouch tissue and angiotensin peptide generation. J Mol Cell Cardiol 30:1401–1413.
van Krimpen C, Schoemaker RG, Cleutjens JPM, Smits JFM, Struyker-Boudier HAJ, Bosman FT, Daemen MJAP. 1991. Angiotensin I converting enzyme inhibitors and cardiac remodeling. Basic Res Cardiol 86(Suppl 1):149–155.
Smits JFM, van Krimpen C, Schoemaker RG, Cleutjens JPM, Daemen MJAP. 1992. Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content. J Cardiovasc Pharmacol 20:772–778.
Jugdutt BI, Amy RWM. 1986. Healing after myocardial infarction in the dog: changes in infarct hydroxyproline and topography. J Am Coll Cardiol 7:91–102.
Sun Y, Weber KT. 1996. Angiotensin-Converting enzyme and wound healing in diverse tissues of the rat. J Lab Clin Med 127:94–101.
Willems IEMG, Havenith MG, De Mey JGR, Daemen MJAP. 1994. The α-smooth muscle actin-positive cells in healing human myocardial scars. Am J Pathol 145:868–875.
Sun Y, Weber KT 2000. Infarct scar: a dynamic tissue. Cardiovasc Res 46:250–256.
Lefroy DC, Wharton J, Crake T, Knock GA, Rutherford RAD, Suzuki T, Morgan K, Polak JM, Poole-Wilson PA. 1996. Regional changes in angiotensin II receptor density after experimental myocardial infarction. J Mol Cell Cardiol 28:429–440.
Hao J, Ju H, Zhao S, Junaid A, Scammell-La Fleur T, Dixon IM. 1999. Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. J Mol Cell Cardiol 31:667–678.
Deten A, Holzl A, Leicht M, Barth W, Zimmer HG. 2001. Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats. J Mol Cell Cardiol 33:1191–1207.
Kalkman EA, van Haren P, Saxena PR, Schoemaker RG. 1997. Regionally different vascular response to vasoactive substances in the remodelled infarcted rat heart; aberrant vasculature in the infarct scar. J Mol Cell Cardiol 29:1487–1497.
Sappino AP, Schürch W, Gabbiani G. 1990. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 63:144–161.
Gabbiani G, Hirschel BJ, Ryan GB, Statkov PR, Majno G. 1972. Granulation tissue as a contractile organ. A study of structure and function. J Exp Med 135:719–734.
Appleton I, Tomlinson A, Colville-Nash PR, Willoughby DA. 1993. Temporal and spatial immunolo-calization of cytokines in murine chronic granulomatous tissue. Implications for their role in tissue development and repair process. Lab Invest 69:405–414.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Weber, K.T. (2003). Infarct Scar. Living Tissue. In: Singal, P.K., Dixon, I.M.C., Kirshenbaum, L.A., Dhalla, N.S. (eds) Cardiac Remodeling and Failure. Progress in Experimental Cardiology, vol 5. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-9262-8_23
Download citation
DOI: https://doi.org/10.1007/978-1-4419-9262-8_23
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4864-1
Online ISBN: 978-1-4419-9262-8
eBook Packages: Springer Book Archive